Who are our Sponsors & Exhibitors?

Cisbio Bioassays, member of IBA group, is a global developer of products, technologies and services used in assay development and drug screening. The company is offering a large variety of reagents and assay kits based on its proprietary technology, HTRF®, a highly sensitive, robust fluorescence technology for the investigation of molecular events under a cell-based format, and widely used by the pharmaceutical industry. More info at www.htrf.com

ChanTest are experts in ion channel and GPCR research. With over 10 years experience, ChanTest has tested small and large molecule compounds for more than 250 companies around the world, publishing more than 300 peer-reviewed papers. Through its representative in Europe Cambridge Bioscience, ChanTest offers clients across Europe access to this important range of products and services with a high level of service and support from an experienced, Europe based team.

www.bioscience.co.uk

Cellecta provides contract research services for the discovery and characterization of novel drug targets, and the development of novel therapeutics.  Cellecta’s genome-wide and targeted RNAi screening platform, which combines complex lentiviral shRNA expression libraries with HT sequencing, enables identification of genes regulating a variety of cellular responses and possible therapeutic targets and helps researchers identify new targets, prioritize known targets, characterize therapeutic mechanisms of action, and identify genes that induce an additive or synergistic response.  The approach is particularly useful in elucidating the mechanism of action for compounds or other factors triggering cellular responses, and for investigators interested in identifying essential genes in cancer models, finding cell signaling nodes modulating a functional response, or looking for genes that confer pathogenic resistance.

Merck Millipore is the Life Science division of Merck KGaA of Germany, offering a broad range of innovative, performance products, services and business relationships that enable our customers’ success in research, development and production of drug therapies. Merck Millipore serves as a strategic partner to our customers and helps advance the promise of life science.

www.merckmillipore.com

Bachem is an independent, technology-based, public biochemicals company providing full service to the pharma and biotech industry.

Bachem is specialized in the process development and the manufacturing of peptides and complex organic molecules as active pharmaceutical ingredients (APIs), as well as innovative biochemicals for research purposes.
With Melusine® - Unexplored Libraries of Peptides & Proteins prepared and pre-fractionated by Atheris Laboratories  - Bachem offers a first-class and innovative tool for lead discovery among peptide toxins, ready-to-use in screening programs.

Bachem has acquired considerable experience in the GMP production of HPAIs and cytotoxics.

With headquarters in Bubendorf, Switzerland, and affiliates in Europe and the US, Bachem works on a global scale and holds a leading position in the field of peptides.

CCS Cell Culture Service provides the custom generation of recombinant assay cell lines and
supplies custom cell based reagents, i.e. assay ready frozen cells, cell membranes, recombinant
proteins. CCS has established transient bulk transfection by scalable electroporation which allows
to transfect batches of 10 billion cells in 30 minutes with your target of interest. Bulk quantities
of assay ready frozen cells can now be rapidly prepared.

Hamamatsu Photonics is a world-leading manufacturer of optoelectronics, providing solutions for a wide range of applications including drug screening and assay development. The FDSS series of whole plate readers from Hamamatsu are fast, reliable, cost-effective and highly sensitive imaging based systems in a flexible, modular format, ideal for all your drug screening needs.

Life Technologies Corporation (NASDAQ:LIFE) is a global biotechnology tools company dedicated to improving the human condition. Our systems, consumables and services enable researchers to accelerate scientific exploration, driving to discoveries and developments that make life even better. Life Technologies customers do their work across the biological spectrum, working to advance personalized medicine, regenerative science, molecular diagnostics, agricultural and environmental research, and 21st century forensics. Life Technologies had sales of more than $3 billion in 2008, employs approximately 9,500 people, has a presence in more than 100 countries, and possesses a rapidly growing intellectual property estate of approximately 3,600 patents and exclusive licenses. Life Technologies was created by the combination of Invitrogen Corporation and Applied Biosystems Inc. For more information on how we are making a difference please visit our website: http://www.lifetechnologies.com/featured-solutions/biotherapeutics-and-vaccine-production.html . Follow Life Technologies on Twitter @LIFECorporation

Technology Networks was established over 10 years ago with the aim of providing informative websites for life science professionals. From our UK headquarters near Sudbury, in Suffolk, we run, update and provide an outstanding web-based information solution for those working within the Life Science and Drug Discovery community.
Since its humble beginnings running just one website based on Combinatorial Chemistry, Technology Networks has expanded its portfolio to include over 30 communities, all of which are available through www.technologynetworks.com/HTS